Beijing Xiangrui Import and Trade Technology Co., Ltd.

Hello, friends, patients. As some cancer specific drugs, molecular targeted therapy drugs, most cancer patients simply cannot afford drugs through regular channels. With so advanced technology, why are there still so many problems that cannot be solved? As family members of cancer patients and the patients themselves, we may be even more troubled by this problem. However, the problem that is more troublesome than facing the problem of being unable to cure cancer is that although people suffering from cancer are in pain, they cannot afford effective drugs. Most of the specific drugs for some cancer diseases are molecular targets. Treatment drugs: Although a large proportion of cancers are incurable, for some patients, certain specific drugs can have an almost immediate effect and can prolong the patient's life to varying degrees. But such a specific drug is the biggest headache for most patients and their families. Perhaps this is because of the special effects of this molecular targeted therapy drug, so the price of this kind of special drug for cancer patients is very high through domestic regular channels. For example, the kind of special drug mentioned above, after taking one Calculated as one pill per month or day, the cost is yuan. Such a high price is unaffordable for many families of cancer patients. Compared with when he was diagnosed with cancer a year ago, Li Tai's father's condition has improved. His coughing has decreased and he is willing to talk to people. In Li Tai's opinion, these changes are all attributed to an anti-cancer drug called Iressa. As a molecular targeted therapy drug, Iressa prevents the growth of cancer cells by acting on specific molecular targets necessary for tumor growth. Unlike traditional chemotherapy drugs, this drug does not accidentally damage cells in normal tissues while killing tumor cells. In recent years, molecularly targeted therapeutic drugs have gradually become the new favorite in cancer treatment. Liu Ruiqi, former director of the Oncology Department of the Beijing Military Region General Hospital, told a reporter from China Youth Daily that molecular targeted therapy drugs such as Iressa are effective drugs for certain eligible lung cancer patients. For some patients, Iressa even has an immediate effect, extending the patient's life to varying degrees.